ArticleNeurosurgical review2025
Analysis of factors influencing diagnostic yield and target point error in robot-assisted stereotactic brain biopsy: a single-center experience.
Article in Neurosurgical review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Non-diagnostic stereotactic intracranial biopsies: a 15-year institutional experience.Journal of neuro-oncology · 2026Article
- Diagnostic performance and safety of stereotactic frame-based biopsy for sub centimeter intracranial lesions: A matched cohort analysis.Neurosurgical review · 2026Article
- Frameless robotic stereotactic brain biopsy workflow with CT-MRI fusion and CT-to-fluoroscopy registration: Step-by-step technical note and early experience.Brain & spine · 2026Article
- Robot-assisted frameless brain biopsy with computed tomography-to-fluoroscopy registration: Step-by-step surgical video.Surgical neurology international · 2026Article
- Three-dimensional structured-light robot-assisted frameless versus frame-based stereotactic brain biopsy: a retrospective study of 54 patients.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Robot-assisted brain tissue biopsy plays a pivotal role in diagnosing complex intracranial lesions. This study retrospectively examines the factors influencing the diagnostic yield and target point error (TPE) in frameless intracranial stereotactic brain biopsy using the Remebot surgical robot. The clinical data of 584 patients who underwent robot-assisted stereotactic brain biopsy at Xuanwu Hospital, China, between April 2019 and December 2023 were analysed. The data collected included histopathological diagnosis results and TPEs. Univariate and multivariate logistic regression analyses were performed to explore the factors influencing diagnostic yield. Multivariate linear regression was used to analyse the factors influencing TPE. MRI enhancement was an independent factor influencing the diagnostic yield, with enhanced lesions showing a higher rate (OR = 0.017, 95% CI: 0.007-0.041; P < 0.001). Larger target volumes were also correlated with higher positivity rates (OR = 1.484, 95% CI: 1.259-1.751; P < 0.001). Smaller TPEs were associated with higher positivity rates (OR = 0.103, 95% CI: 0.045-0.233; P < 0.001). Larger entry point tangential angles resulted in smaller TPEs (b = -0.093, t = -38.034, P < 0.001), and supratentorial locations had smaller errors than infratentorial locations did (b = -0.514, t = -9.182, P < 0.001). Markpoint registration was more accurate than facial laser scanning registration was (b = -0.064, t = -2.484, P = 0.013). Robot-assisted frameless stereotactic biopsy is an accurate and safe method. It is crucial to strictly adhere to the surgical indications, such as selecting cases with significant imaging enhancement. The puncture path should be planned rationally, with the biopsy needle inserted as vertically as possible to the cranial surface. A more suitable registration method should be chosen, and if higher precision is required, marked point registration should be used. This will ensure the accuracy of the target and achieve a higher diagnostic yield.
Indexed as
Identifiers
40126726What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.